Profile data is unavailable for this security.
About the company
111, Inc. is a China-based Internet medical and health company. The Company is mainly engaged in the provision of online medical services, drug purchasing and health management services through Internet and information technology. The Company mainly conducts its business in the domestic market.
- Revenue in USD (TTM)2.04bn
- Net income in USD-51.74m
- Incorporated--
- Employees1.52k
- Location111 Inc3-4/FNo.295 Zuchongzhi Road, Pudong New AreaSHANGHAI 201203ChinaCHN
- Phone+86 2 120536666
- Websitehttp://gangling.111.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hyphens Pharma International Ltd | 126.76m | 6.37m | 63.18m | 440.00 | 9.93 | 1.35 | 7.47 | 0.4984 | 0.0277 | 0.0277 | 0.5513 | 0.2037 | 1.45 | 4.65 | 4.89 | 387,715.90 | 7.29 | 8.35 | 12.10 | 14.01 | 36.29 | 37.06 | 5.03 | 5.65 | 1.35 | -- | 0.0939 | 33.00 | 5.10 | 7.12 | -24.52 | 9.63 | -18.70 | 9.35 |
| Harima-Kyowa Co., LTD. | 394.47m | 9.01m | 72.85m | 197.00 | 7.98 | 0.4655 | 7.80 | 0.1847 | 261.75 | 261.75 | 11,459.40 | 4,490.24 | 1.91 | 23.79 | 5.51 | -- | 4.36 | 4.39 | 5.70 | 5.87 | 11.57 | 11.73 | 2.28 | 2.23 | 2.22 | -- | 0.0131 | 17.15 | 2.37 | 5.01 | 1.10 | 3.25 | 34.30 | 3.44 |
| Balaxi Pharmaceuticals Ltd | 29.03m | -287.21k | 79.05m | 51.00 | -- | 3.22 | -- | 2.72 | -0.566 | -0.566 | 46.75 | 36.96 | 0.969 | 1.37 | 4.47 | -- | -0.9586 | 19.81 | -1.22 | 27.30 | 46.67 | 35.46 | -0.9893 | 11.95 | 2.36 | 26.61 | 0.0879 | -- | -28.28 | 77.76 | -105.19 | -- | 5.11 | -- |
| Natural Health Trends Corp. | 43.01m | 499.00k | 79.58m | 138.00 | 159.11 | 2.02 | 122.06 | 1.85 | 0.0434 | 0.0434 | 3.75 | 3.42 | 0.582 | 2.24 | -- | 311,695.70 | 0.6751 | -0.5398 | 0.9333 | -0.7099 | 74.30 | 74.06 | 1.16 | -0.9571 | 2.77 | -- | 0.00 | -- | -10.60 | -25.54 | 81.47 | -54.86 | -26.47 | 6.64 |
| 111 Inc - ADR | 2.04bn | -51.74m | 100.95m | 1.52k | -- | -- | -- | 0.0495 | -0.6106 | -0.6106 | 24.07 | -1.04 | 4.80 | 9.62 | 32.62 | 1,342,754.00 | -10.93 | -17.09 | -- | -178.25 | 5.56 | 5.36 | -2.28 | -4.37 | 0.5234 | -19.99 | 0.4256 | -- | 10.59 | 52.95 | 5.80 | -- | -7.89 | -- |
| Pharmaniaga Berhad | 723.28m | -16.45m | 110.23m | 3.78k | -- | -- | -- | 0.1524 | -0.0572 | -0.0572 | 2.55 | -0.2056 | 1.82 | 4.59 | 9.57 | -- | -4.06 | -6.88 | -- | -38.45 | 9.04 | 6.64 | -2.23 | -3.66 | 0.2762 | 1.37 | 1.29 | -- | -3.02 | 7.38 | 87.25 | -- | 23.35 | -- |
| Sopharma Trading AD | 962.93m | 17.54m | 111.54m | 2.73k | 6.36 | 1.47 | 3.13 | 0.1158 | 0.9201 | 0.9201 | 50.50 | 3.98 | 2.66 | 0.1586 | 7.16 | 661,702.60 | 4.85 | 2.39 | 14.87 | 7.88 | 97.98 | 98.09 | 1.82 | 1.01 | 0.6231 | 185.95 | 0.6107 | -- | 13.02 | 13.26 | 221.67 | 27.86 | 3.70 | -- |
| Profarma Distribuidora de Produts Frm SA | 1.69bn | 14.69m | 124.35m | 7.08k | 8.38 | 0.5151 | 2.73 | 0.0734 | 0.6289 | 0.6289 | 72.50 | 10.23 | 1.77 | 4.67 | 7.67 | -- | 1.70 | 1.64 | 4.06 | 3.40 | 14.97 | 14.61 | 0.9618 | 0.9519 | 0.7696 | 1.85 | 0.4552 | -- | 10.82 | 15.19 | -12.95 | -- | 41.08 | -- |
| Charmacy Pharmaceutical Co Ltd | 608.74m | 7.10m | 129.41m | 831.00 | 18.23 | 1.57 | 12.03 | 0.2126 | 0.5139 | 0.5139 | 44.07 | 5.98 | 1.44 | 6.05 | 4.88 | 5,728,231.00 | 1.68 | 1.79 | 8.28 | 7.99 | 6.34 | 6.08 | 1.17 | 1.24 | 0.7775 | 2.79 | 0.5111 | 37.09 | 5.47 | 2.27 | -43.25 | 2.48 | -16.01 | 0.0027 |
Data as of Jun 04 2024. Currency figures normalised to 111 Inc's reporting currency: US Dollar USD
4.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 710.60k | 1.48% |
| Greenwoods Investments SG Pte Ltd.as of 31 Mar 2024 | 348.86k | 0.73% |
| Barclays Bank Plc (Private Banking)as of 31 Mar 2024 | 329.80k | 0.69% |
| Wellspring Financial Advisors LLCas of 31 Mar 2024 | 180.17k | 0.38% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 114.39k | 0.24% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 98.64k | 0.21% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 46.88k | 0.10% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 35.97k | 0.08% |
| Citadel Securities LLCas of 31 Mar 2024 | 34.05k | 0.07% |
| Geode Capital Management LLCas of 31 Mar 2024 | 33.10k | 0.07% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
